Klaus-Juergen Koelln

Title: Klaus-Juergen Koelln: Innovator in Pharmaceutical Technology

Introduction

Klaus-Juergen Koelln is a notable inventor based in Neustadt am Rübenberge, Germany. He has made significant contributions to the field of pharmaceutical technology, particularly in the development of innovative drug delivery systems. His work has led to the creation of a unique formulation that enhances the effectiveness of pancreatin.

Latest Patents

Klaus-Juergen Koelln holds 1 patent for his invention titled "Pancreatin micropellets prepared with polyethylene glycol 4000, paraffin." This patent describes a method for preparing pancreatin-containing micropellet cores that can be coated with a gastric juice-resistant film. The process involves extruding a mixture of pancreatin, polyethylene glycol 4000, and a lower alcohol, such as propan-2-ol, to create extrudates that break into fragments. These fragments are then rounded with highly liquid paraffin and dried. The micropellet cores consist of 65-85% pancreatin and exhibit a bulk density of 0.6 g/ml to 0.85 g/ml, with a spherical to ellipsoidal shape.

Career Highlights

Klaus-Juergen Koelln is associated with Kali-Chemie Pharma GmbH, where he has been instrumental in advancing pharmaceutical formulations. His innovative approach to drug delivery has positioned him as a key figure in the industry.

Collaborations

Klaus-Juergen Koelln has worked alongside notable colleagues, including Bernd Boedecker and Alwin Sobe. Their collaborative efforts have contributed to the success of various projects within the pharmaceutical sector.

Conclusion

Klaus-Juergen Koelln's contributions to pharmaceutical technology through his innovative patent demonstrate his commitment to improving drug delivery systems. His work continues to influence the field and enhance patient care.